Active substance

W-135) conjugate vaccine

On 1 register3 medicines

Where it is registered

Each register with its number of medicines and a few of them.

Every register, a page at a time. Strengths and packs are on each medicine’s page.

10 results

Medicine	Register	Strength	Form	Status	Holder
MenQuadfiCombination	New Zealand		Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial	Funded
NimenrixCombination	New Zealand		Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier in 0.5 ml vial	Funded
NimenrixCombination	New Zealand		Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial	Funded
MenactraCombination	United States	48UG/.5ML	For Injection	Marketed	Sanofi Vaccines US Inc.
MenveoCombination	United States	0.5ML	Injection	Marketed	GlaxoSmithKline Biologicals
MenveoCombination	United States	0.5ML	Injection	Marketed	GlaxoSmithKline Biologicals
MenQuadfi	European Union			Authorised	Sanofi Winthrop Industrie
Menveo	European Union			Authorised	GSK Vaccines S.r.l.
Nimenrix	European Union			Authorised	Pfizer Europe MA EEIG
MenactraCombination	Canada	4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML	Solution	Cancelled	Sanofi Vaccines Canada LTD.

The same brand on several registers.

Substances it shares a medicine with.

Compiled by Prognia from the public medicine registers of PHARMAC. Each medicine’s page names its own source, licence and attribution.

Report an error or request removalCorrections from a register or a company are welcome.

For reference and learning, not treatment advice. Always check the official product information.